Varman T. Samuel - Concepedia

Author

Varman T. Samuel

Also Known As

Samuel,Vanessa, V Samuel, V. Samuel, V. T. Samuel, VARMAN SAMUEL, Varman Samuel, Varman T Samuel, Varman T. Samuel, Varman T. Samuel, Vijay Samuel

133

Publications

21.4K

Citations

H-Index

Concepts

All Affiliations

Yale University Howard Hughes Medical Institute Ionis Pharmaceuticals (United States)Veterans Health Administration VA Connecticut Research and Education Foundation

About

Varman T. Samuel is an author at Yale University specializing in medicine, health sciences, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	44	7.4K
2	Health Sciences	31	40	6.1K
3	Biochemistry	23	24	4.4K
4	Public Health	1	1	518
5	Biostatistics	1	1	706

Varman T. Samuel

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease Varman T. Samuel, Zhen Xiang Liu, Xianqin Qu, Journal of Biological Chemistry	2004	1.3K
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase Anila K. Madiraju, Derek M. Erion, Yasmeen Rahimi, Nature Mitochondrial FunctionBiochemistryPhysiologyMetabolic RegulationMetabolism	2014	1.3K
Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice Julio E. Ayala, Varman T. Samuel, Gregory J. Morton, Disease Models & Mechanisms Metabolic DisorderGlucose HomeostasisMmpc ConsortiumMetabolic RemodelingObesity	2010	706
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis Sara A. Beddow, Varman T. Samuel, Paul L. Miller, Science	2011	604
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease Naoki Kumashiro, Derek M. Erion, Dongyan Zhang, Proceedings of the National Academy of Sciences	2011	562
Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype Maryam Ahmadian, Marcia J. Abbott, Tianyi Tang, Cell Metabolism ObesityMetabolic SyndromeInsulin SignalingSignal TransductionDesnutrin/atgl Is	2011	525
Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association Harold Bays, Peter P. Tóth, Penny M. Kris‐Etherton, Journal of clinical lipidology ObesityMetabolic SyndromeNutritionLipid DisorderHealth Policy	2013	518
Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease Varman T. Samuel, Zhenxiang Liu, Amy Wang, Journal of Clinical Investigation PathologyInsulin ReceptorFatty Liver DiseaseInsulin SignalingObesity	2007	475
Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance Cheol Soo Choi, David B. Savage, Ameya Kulkarni, Journal of Biological Chemistry Plasma Fatty AcidsPathologyFatty Liver DiseaseInsulin SignalingMetabolic Syndrome	2007	369
Targeted Expression of Catalase to Mitochondria Prevents Age-Associated Reductions in Mitochondrial Function and Insulin Resistance Hui‐Young Lee, Cheol Soo Choi, Andreas L. Birkenfeld, Cell Metabolism Insulin ResistanceMitochondrial FunctionBiochemistryPhysiologyCatabolism	2010	311

Page 1